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ABSTRACT
The sebaceous gland, long considered an evolutionary relic with little-to-no physiological relevance
in humans, has emerged in recent decades as a key orchestrator and contributor to many
cutaneous functions. In addition to the classical physico-chemical barrier function of the skin
against constant environmental challenges, a more novel, neuro-immune modulatory role has also
emerged. As part of the complex intercellular communication network of the integumentary
system, the sebaceous gland acts as a “relay station” in the skin for many endocrine factors. This
review aims to offer a comprehensive overview of endocrine effects and subsequent interactions on
this much maligned mini-organ.
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Introduction
The sebaceous gland, long considered an evolutionary
relic with little-to-no physiological relevance in
humans, has emerged as a key orchestrator and con-
tributor to many cutaneous functions. These include
the classical physico-chemical barrier function of the
skin against constant environmental challenges, as
well as more novel, neuro-immune modulatory roles
and complex intercellular communication networks of
the integumentary system. All of these processes are
not only deﬁned by local factors, but greatly inﬂu-
enced by the endocrine system. This review aims to
offer a comprehensive overview of endocrine effects
and interactions on this much maligned mini-organ.
The sebaceous gland – anatomy and functions
The sebaceous gland, comprised of sebocytes, is
located in the dermis of the skin of all terrestrial mam-
mals, primarily associated with hair follicles and the
arrector pili muscles forming the pilosebaceous
unit.1,2 There is also great intra-individual variability
in the distribution of sebaceous glands, since the den-
sity of the glands in various regions of the body is
markedly different. The sebaceous gland differentiates
in the embryonic stage between months 2 and 4 of
gestation, with the rest of the pilosebaceous unit. Dur-
ing this process, a population of B lymphocyte-
induced maturation protein 1 expressing unipotent
stem cells is established,3 which are responsible for
regenerating the sebaceous gland in adult skin,
although stem cells from the bulge region of the hair
follicle may also act as a source of sebocytes.4,5 The
fully formed sebaceous gland found in adult skin may
be divided into three zones, containing sebocytes in
distinct stages of differentiation. The outermost
peripheral zone contains the least differentiated, mitot-
ically active population. These cells grow in size as
they move centrally, differentiate, and accumulate
lipid droplets, forming the maturation zone. As the
ﬁnal step of their differentiation sebocytes disintegrate
and release their content via holocrine section in the
central necrosis zone.1,4 This continuous differentia-
tion program is coordinated by a wide range of neural,
paracrine, and endocrine mediators,6 the latter of
which is the main focus of this review.
The main function of the sebaceous gland is the
holocrine production of sebum (tallow), the
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composition of which shows marked species speci-
ﬁcity. Sebum is mostly composed of various neutral
lipids (triglycerides, free fatty acids, wax esters,
cholesterol and squalene), of which squalene and
wax esters are unique and typical components. The
main function of these secreted lipids is to cover
the fur and the surface of the skin, and unsurpris-
ingly they constitute the majority of skin surface
lipids.7-9 While sebum plays important roles in the
impregnation of fur and thermal insulation as well
as the production of pheromones in animals, these
functions are mostly unrecognizable in humans,
leading to the long-standing view that the human
sebaceous gland is an evolutional relic.10,11 This
view has changed dramatically over more recent
decades, since the composing lipids are important
in skin barrier function, water resistance and pro-
tection from sunburn and UV radiation,12-14 as
well as in the establishment of the commensal bac-
terial ﬂora of the skin.13,15
The sebaceous gland is not only notable as a
producer of sebum, a structural constituent of the
skin, but has other functions as well, most notably
its contribution to the local immunological milieu.
Sebocytes are capable of producing a wide range of
(mainly pro-inﬂammatory) cytokines (interleukin
[IL]-1a; IL1-b; IL-6; IL-8/CXCL-8 and tumor
necrosis factor-a [TNFa]) and lipid-derived media-
tors.16,17 The production of these factors is usually
initiated by inﬂammatory factors, such as the pres-
ence of bacteria or certain endogenous mediators.
Propionibacterium acnes, a known pathogenic fac-
tor in the development of acne, leads to the pro-
duction of TNFa and IL-8/CXCL-8, while bacterial
lipopolysaccharide (LPS) elevates IL-1a as well.16
The endogenous inﬂammatory mediator arachi-
donic acid (AA) and the elevation intracellular cal-
cium by the ionophore A23187 increased the
release of IL-6 and ¡8.17 Interestingly the activa-
tion of the calcium permeable channel, transient
receptor potential vanilloid-1 (TRPV1) with capsai-
cin instead decreased the release of IL-1b.18
AA-derived lipid mediators produced through the
cyclooxygenase or lipoxygenase pathways (key
enzymes of which are expressed on sebocytes) may
also play a key role as inﬂammatory signals.19 It is
not just inﬂammatory mediators that can elicit
these effects, but various hormones and neuropepti-
des including hypothalamic and pituitary
hormones, i.e. corticotropin-releasing hormone
(CRH) and a-melanocyte stimulating hormone
(aMSH); for more detail see below in the relevant
sections.
Sebaceous glands as sources and targets
of sexual steroids
The link between sebaceous gland function and sexual
steroids, most notably androgens, was established in
the middle of the 20th century, more-or-less concur-
rently on animal models and humans.20-24 Supporting
these early forays into androgen effects on sebaceous
physiology more recent works have proven the expres-
sion of androgen receptors both in situ25,26 and in
vitro27 on human sebocytes. Androgens were also
shown to increase the proliferation of sebocytes in cul-
ture,27,28 although they can only stimulate the lipid
synthesis of these cells in the presence of certain co-
activators (e.g. linoleic acid, which stimulates peroxi-
some proliferator activated-receptors [PPARs]).29,30 A
more recent study has shown that in vitro models of
the sebaceous gland lack androgen receptors (which
may be found in situ on sebocytes), and that if reintro-
duced on these cells they are once again capable of
responding to androgens without co-activators.31 Fur-
ther adding to the complexity of these results it was
also reported in primary isolated sebocytes that the
location of the sebaceous gland inﬂuences the effect of
androgens; namely, these hormones were more effec-
tive in increasing the proliferation of facial sebocytes
than on non-facial ones.32-34
The sebaceous gland appears to be much more
than a target for androgens, however. These cells
have been shown to express P450 side chain cleav-
age system which converts cholesterol to pregneno-
lone,35 as well as multiple androgen metabolizing
enzymes (3b-hydroxysteroid dehydrogenase/D5-4-
isomerase, 17b-hydroxysteroid dehydrogenase [17b-
HSD2], 5a-reductase-1, and 3b-hydroxysteroid
dehydrogenase). They are also capable of synthesiz-
ing testosterone and of converting said testosterone
into 5a-dihydrotestosterone (5a-DHT) which pro-
cess, like lipid synthesis, was promoted by a simul-
taneous activation of PPARs.36 An inverse
correlation was also found between the expression
of 17b-HSD2 and PPARg in differentiated sebo-
cytes in situ.37 Conversely, sebocytes are also
able to inactivate testosterone by converting it to
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ﬁrst androstenedione and then further to 5a-
androstenedione.27,38
In contrast to the pro-lipogenic actions of andro-
gens, estrogens were originally described to have
opposite effects, namely to decrease the proliferation
of sebocytes and to inhibit the production of
sebum.39,40 Patients with acne have also been shown
to have lower serum estradiol and sex hormone
binding globulin levels,41,42 and combined oral con-
traceptive therapy has been shown to be beneﬁcial
in acne patients,43 supporting the idea that estrogens
decrease the function of the sebaceous gland. How-
ever, more recent reports have offered conﬂicting
evidence, since whilst the expression of estrogen
receptor –a and –b was described on sebaceous
glands,26 17b-estradiol and progesterone had no
discernable effect on either the proliferation or on
the lipid production of SZ95 sebocytes.44
Role of hypothalamic-pituitary-adrenal (HPA)
axis hormones in control of sebaceous glands
Sebocytes express ligands and receptors for a broad
range of hormones of the hypothalamic-pituitary-
adrenal gland axis. Corticotropin releasing hormone
(CRH), the master regulator of the HPA axis, can tar-
get the CRH receptor-1 and 2 (CRHR1, CRHR2)
expressed in sebocytes.45,46 Beyond the receptors,
sebaceous cells also express the CRH binding protein46
which can negatively regulate the effect of CRH by
binding and neutralizing it.47 Supporting the func-
tional role of the CRHRs in control of sebaceous func-
tions, CRH (and to a lower extent urocortin, another
CRHR agonist) was found to increase sebum produc-
tion and inhibit proliferation, hallmarks of enhanced
differentiation.46,48 CRH was also found to stimulate
IL-6 and IL-8 release48 and increased mRNA expres-
sion of 3b-Hydroxysteroid dehydrogenase/D5-4 isom-
erase,46 a key enzyme of steroid hormone synthesis.
Moreover, CRH peptide and its mRNA was also
detected in cultured sebocytes, suggesting a possible
autocrine effect in the regulation of sebaceous
functions.46,48
Hormones of the HPA axis downstream from CRH,
as well as their receptors, were also detected in sebo-
cytes. Proopiomelanocortin (POMC) and its deriva-
tives, adrenocorticotropic hormone (corticotropin,
ACTH), a- and b melanocyte stimulating hormone
(melanocortin, MSH), and b-endorphin were
described in sebocytes, as well as prohormone conver-
tase enzymes which are responsible for the enzymatic
cleavage of POMC.49-51 Several receptors of the
aMSH and ACTH, i.e. melanocortin receptor-1, 2 and
5 (MC-1R, MC-5R) are also expressed in sebocytes
with a functional role in the control of sebaceous dif-
ferentiation and lipid synthesis. Indeed, MSH and
ACTH treatment induced differentiation and lipogen-
esis and decreased IL-1b induced IL-8 secretion. Sug-
gesting its speciﬁc role, MC-5R was found only in
differentiated sebocytes and characterized as a poten-
tial differentiation marker in sebaceous glands.52-54
Moreover, m-opioid receptors were also reported in
sebocytes and b-endorphin was suggested to stimulate
lipogenesis.55
The expression of the HPA axis in sebaceous glands
suggests the presence of a local endocrine “stress axis”,
which might be involved in cutaneous/sebaceous
stress responses. This hypothesis is supported by ﬁnd-
ings that CRH expression was elevated in sebaceous
glands of acne affected skin56 and upregulated in aged
skin.57 Like CRH, MC-1R also showed an increased
expression in acne-affected skin.58
Growth hormones controlling sebaceous glands
Growth factors and hormones promoting growth have
been extensively shown to inﬂuence sebaceous gland
functions. Most notably the overproduction of growth
hormone (GH) is commonly associated with “oily
skin”. In accordance with these results it was shown
that GH receptors are not only expressed in skin,59
but more speciﬁcally in the sebaceous glands in
situ.60,61 Supporting the functional effect of GH, it was
shown that the hormone accelerated the differentia-
tion of sebocytes in a rat preputial model, while having
little effect on their proliferation. This is in contrast to
insulin-like growth factor 1 (IGF-1), which mainly
affected proliferation of the cells. Insulin, the “univer-
sal growth hormone” stimulated both proliferation
and differentiation as well as augmenting the above
mentioned effects of GH, IGF-1 and 5a-DHT.62 In
human in vitro models, IGF-1 and GH had similar
effects, with IGF-1 being the more efﬁcacious of the
two,44 acting through the PI-3-kinase/Akt/sterol
response element-binding protein-1 (SREBP1) path-
way.63,64 Further supporting the role of this axis in the
pathogenesis of acne it was recently shown that IGF-1
also increases the production of inﬂammatory
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cytokines and sebum from cultured primary human
sebocytes and the commonly used cell line SZ95.65,66
Epidermal growth factor (EGF), a more “local”
growth hormone may also have direct effects on sebo-
cytes, which express its receptor (EGFR).67 In human
in vitro systems EGF inhibits differentiation, which
coincides with the observation that one of the reported
side effects of EGFR inhibitor antibody (cetuximab)
treatment are acneiform eruptions.68 These ﬁndings
further highlight the inadequacy of animal models in
studying sebocyte biology, since in hamster sebaceous
glands EGF increased the number of cells.69 Interest-
ingly, a more recent paper has shown that cetuximab
does not induce inﬂammatory mediator release from
in vitro cultured sebocytes, while it does increase their
lipogenesis.70,71 This hints at the possibility that a
more complex signaling network is responsible for the
aforementioned lesions. Besides EGF, the role of ﬁbro-
blast growth factor receptor-2b (FGFR2b) coupled sig-
naling in the control of sebaceous functions and the
development of acne has also been proposed.72,73
Central role of sebocytes in the cutaneous
endocannabinoid system
As detailed above, several systemic hormones regulate
local cutaneous lipid homeostasis, controlling seba-
ceous lipid, and paracrine/endocrine mediator pro-
duction. However, sebaceous glands are not only
sources of lipids, but also stand under the control of
locally produced lipid mediators among which endo-
cannabinoids (ECs) emerge.74 ECs, sharing molecular
targets with the active ingredients of the plant Canna-
bis sativa, are locally produced arachidonic acid deriv-
atives which activates, among else, G protein-coupled
cannabinoid receptors CB1 and CB2. These endoge-
nous mediators, their receptors and the enzymatic sys-
tem involved in their synthesis and metabolism form
the endocannabinoid system (ECS), a powerful regula-
tory network virtually presented in all tissues.75 In the
skin, similar to other organs, an EC tone is established
by the regulated production and degradation of the
ECs among which the most studied ones are the
arachidonoylethanolamine (anandamide or AEA) and
2-arachidonoylglycerol (2-AG).74 Both AEA and
2-AG are produced by epidermal keratinocytes76 hair
follicles77 and sebocytes,78 as well. The established EC
tone is not only analgesic limiting neural excitation
at the sensory terminals,79,80 but it may exert
anti-inﬂammatory, immunosuppressive, anti-allergic
and itch inhibiting effect.81,82 Moreover, ECs induce
apoptosis of epidermal keratinocytes,83 modulate their
differentiation and barrier formation76,84 and inhibit
hair growth.77
Human sebaceous glands and cultured sebocytes
express CB2 which mediates the lipogenic effect of
endocannabinoids. AEA and 2-AG enhanced the
lipid synthesis of SZ95 sebocytes which was mim-
icked by synthetic CB2 agonists and inhibited by
CB2 antagonists or siRNA mediated CB2 silencing.
In good accordance with their lipogenic effect, ECs
decreased the viability and induced apoptosis of the
cells further supporting their role in promoting
sebaceous differentiation. EC treatment resulted in
a rapid Erk phosphorilation and later in increased
expression of PPARs and target genes. Antagonists
of both MAPK pathway and PPARg inhibited the
effect of the ECs. These data strongly argue for
the involvement of the MAPK-PPAR pathway in
the lipogenic effect of ECs.78 Since both decreased
and increased sebum production can play etiologi-
cal role in several skin diseases, targeting of the
sebaceous endocannabinoid system may have a
notable therapeutic importance.74
Therapeutic properties: Phytocannabinoids
and TRP ion channels
A possible way to utilize the ECS in the skin for
therapeutic purpose is the modiﬁcation of the EC
tone by manipulating the activity of synthesizing or
degrading enzymes.74,85 Indeed, as Karsak et al.81
convincingly demonstrated, the lack of epidermal
cannabinoid signaling in CB1 and CB2 double KO
mice resulted in aggravated allergic skin inﬂamma-
tion but the increased EC tone by genetic ablation
of AEA metabolizing enzyme fatty acid amide
hydrolase (FAAH) attenuated the inﬂammatory
symptoms in a contact dermatitis rodent model. In
a good agreement with the above ﬁndings, we also
demonstrated that FAAH inhibitors (most probably
via restoration of homeostatic anti-inﬂammatory
EC tone) exert anti-inﬂammatory effects in human
keratinocytes by inhibiting TLR2 induced pro-
inﬂammatory signals.86 Since sebocytes are signiﬁ-
cant source of cutaneous ECs,78 their EC produc-
tion can considerably contribute to the elevated EC
tone upon FAAH inhibition, although direct effect
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of FAAH inhibition has not been directly investi-
gated in sebocytes yet.
Another promising approach to inﬂuence cuta-
neous ECS is targeting CB receptors with stable,
exogenous ligands, like phytocannabinoids, the
most well-known active ingredients of the cannabis
plant.85 Surprisingly, (¡)-cannabidiol (CBD) a
non-psychotropic phytocannabinoid, in contrast to
ECs, decreased proliferation, inhibited lipid synthe-
sis and evoked marked anti-inﬂammatory effects
on SZ95 sebocytes.87 The effect of CBD was found
to be independent of CB2 (mediating lipogenic
effect of ECs) and mediated by other molecular tar-
gets. The anti-inﬂammatory effect of CBD were
mediated by the activation of the A2A adenosine
receptor resulting in up-regulation of tribbles
homolog 3 (TRIB3) and consequent inhibition of
the pro-inﬂammatory p65 NF-kB pathway in the
downstream signaling. In contrast, the lipostatic
and anti-proliferative effects of CBD was mediated
by Ca2C inﬂux via TRPV4, a member of the tran-
sient receptor potential vanilloid (TRPV) cation
channels. CBD was also reported as a week activa-
tor of TRPV4 in an earlier study.88 On sebocytes,
CBD inhibited cellular proliferation and suppressed
lipid synthesis induced by arachidonic acid, linoleic
acid and testosterone combination, or AEA. This
general “sebostatic” (lipid decreasing and anti-pro-
liferative) action of CBD was associated with the
inhibition of ERK1/2 MAPK pathway and down-
regulation of nuclear receptor interacting protein 1
(NRIP1, a.k.a. RIP140). Importantly, these effects
of CBD were inhibited by pharmacological block-
ade of TRPV4 and mimicked by a synthetic
TRPV4 agonist, strongly arguing for the sebostatic
role of TRPV48585. Similarly to TRPV4, activation
of TRPV189 and TRPV3 (Szanto et al, unpublished
manuscript) also suppressed lipid synthesis of sebo-
cytes suggesting a lipid synthesis inhibiting effect
for Ca2C-coupled signaling pathways. This conclu-
sion is also supported by the ﬁnding that removal
of extracellular calcium and 1,25 dihydroxyvitamin
D3 increased lipid synthesis of sebocytes.90 Interest-
ingly, we found that other phytocannabinoids can
oppositely inﬂuence the lipid synthesis of sebo-
cytes.91 Like CBD, (¡)-cannabichromene (CBC),
(¡)-cannabidivarin (CBDV) and (¡)-D(9) –tetra-
hydrocannabivarin (THCV) signiﬁcantly reduced
arachidonic acid-induced lipid synthesis whereas
(¡)-cannabigerol (CBG) and (¡)-cannabigerovarin
(CBGV) increased basal sebaceous lipid production.
Although their exact mechanism of action is not
known yet, their different action on sebum produc-
tion may be explained by their different afﬁnity to
CB receptors and/or TRP channels.88,92,93
It is tempting to translate the above experimental
results into therapeutic exploitation. CBD possesses
characteristic of an ideal anti-acne agent, alleviating sev-
eral factors of this abundant inﬂammatory disease: (1) it
exerts anti-inﬂammatory effect, (2) suppresses increased
sebum production, as well as (3) pathologically acceler-
ated cell proliferation in sebaceous glands. Activation of
certain TRP channels and related Ca2C signaling might
also decrease sebum production whereas TRP channel
antagonists or certain (phyto)cannabinoids activating
CB2 or increasing EC tone might be useful in treatment
of dry skin associated diseases.74,85
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